Anti-Human CD15 – PerCP

Pricing & Details

Product No.C2015
Clone
TG1
Protein
CD15
Formats AvailableView All
Product Type
Monoclonal Antibody
Alternate Names
Granulocytes
Isotype
Mouse
IgM
Applications
FC
Prod No.
Size
Price
Avail.
Qty
Add to cart
C2015-Custom
Custom
In stock
Bulk quantities available. Contact us for pricing.

Antibody Details

Product Details

Reactivity Species
Human
Host Species
Mouse
Immunogen
Purified Recombinant Human CD15 (>98%)
Product Concentration
0.1 mg/ml
Formulation
This PerCP conjugate is formulated in 0.01 M phosphate buffered saline (PBS) pH 7.4, 150 mM NaCl, 1% BSA and 0.09% sodium azide as a preservative.
Storage and Handling
This PerCP conjugate is stable when stored at 2-8°C. Do not freeze.
Country of Origin
USA
Shipping
Next Day 2-8°C
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Specificity
Mouse Anti-Human CD15 (Clone TG1) recognizes an epitope on Human CD15. This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Antigen Distribution
The CD15 antigen is present on >95% of mature peripheral blood eosinophils and neutrophils and is present in low density on circulating monocytes. It is absent on normal lymphocytes.1
Background
Anti-Human CD15 can be used for identification or enumeration of mature granulocytes in peripheral blood.

Antigen Details

Protein
PubMed
NCBI Gene Bank ID
Research Area
Cell Biology
.
Immunology
.
Innate Immunity
.
Neuroscience
.
Neuroscience Cell Markers
.
Stem Cell

References & Citations

1. Leukocyte Typing III (1987) Oxford University Press 2. Hogg, N. H. et al. (1984) Immunology 53:753 3. Linch D. C. et al. (1984) Blood 63:566 4. Beverley, P. C. L. et al. (1980) Nature 287:332
Flow Cytometry

Formats Available

Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our cookie policy. Ok